FR2388564A1 - Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation - Google Patents

Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation

Info

Publication number
FR2388564A1
FR2388564A1 FR7809342A FR7809342A FR2388564A1 FR 2388564 A1 FR2388564 A1 FR 2388564A1 FR 7809342 A FR7809342 A FR 7809342A FR 7809342 A FR7809342 A FR 7809342A FR 2388564 A1 FR2388564 A1 FR 2388564A1
Authority
FR
France
Prior art keywords
pseudopest
preparation process
vaccine against
live vaccine
new improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7809342A
Other languages
English (en)
Other versions
FR2388564B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recherche et Industrie Therapeutiques
Original Assignee
Recherche et Industrie Therapeutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recherche et Industrie Therapeutiques filed Critical Recherche et Industrie Therapeutiques
Publication of FR2388564A1 publication Critical patent/FR2388564A1/fr
Application granted granted Critical
Publication of FR2388564B1 publication Critical patent/FR2388564B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention est relative à un vaccin aviaire et à sa préparation. Le vaccin suivant l'invention contient une souche du virus de la pseudopeste aviaire obtenue à partir de la souche P/76/5. Le vaccin de l'invention est utilisable dans la prévention de la pseudopeste aviaire par administration aux poussins sous la forme d'un aérosol.
FR7809342A 1977-04-25 1978-03-30 Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation Granted FR2388564A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE853923 1977-04-25

Publications (2)

Publication Number Publication Date
FR2388564A1 true FR2388564A1 (fr) 1978-11-24
FR2388564B1 FR2388564B1 (fr) 1980-07-25

Family

ID=3861522

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7809342A Granted FR2388564A1 (fr) 1977-04-25 1978-03-30 Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation

Country Status (22)

Country Link
US (1) US4235876A (fr)
AR (1) AR218304A1 (fr)
AT (1) AT358166B (fr)
BE (1) BE853923A (fr)
CA (1) CA1113860A (fr)
CH (1) CH641047A5 (fr)
DE (1) DE2817891A1 (fr)
DK (1) DK160878A (fr)
FI (1) FI59535C (fr)
FR (1) FR2388564A1 (fr)
GB (1) GB1593567A (fr)
HU (1) HU179290B (fr)
IE (1) IE46943B1 (fr)
IL (1) IL54390A (fr)
IT (1) IT1113070B (fr)
LU (1) LU79508A1 (fr)
NL (1) NL7804182A (fr)
NO (1) NO153010C (fr)
PH (1) PH14085A (fr)
PT (1) PT67868B (fr)
SE (1) SE430752B (fr)
ZA (1) ZA781832B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034238A1 (de) * 1979-10-29 1981-05-07 Vsesojuznyj gosudarstvennyj naučno-kontrolnyj institut veterinarnych preparatov, Moskva Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.
US5686077A (en) * 1991-09-20 1997-11-11 Akzo Nobel N.V. Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
ES2188593T3 (es) * 1992-03-24 2003-07-01 United Cancer Res Inst Vacuna que contiene un virus vivo.
US5427791A (en) * 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease
CA2181862C (fr) * 1995-08-01 2009-12-22 Carla Christina Schrier Vaccin antiviral attenue pour la maladie de newcastle
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
HUP0202537A3 (en) 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
KR101481164B1 (ko) * 2008-01-30 2015-01-09 주식회사 미래셀바이오 체세포 유래 다능성 줄기세포의 제조 방법
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
US9956281B2 (en) 2011-05-04 2018-05-01 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US3548054A (en) * 1969-06-06 1970-12-15 Lilly Co Eli Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034238A1 (de) * 1979-10-29 1981-05-07 Vsesojuznyj gosudarstvennyj naučno-kontrolnyj institut veterinarnych preparatov, Moskva Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
IT7822203A0 (it) 1978-04-11
NO781421L (no) 1978-10-26
PH14085A (en) 1981-02-10
CA1113860A (fr) 1981-12-08
DK160878A (da) 1978-10-26
IE46943B1 (en) 1983-11-16
FI781233A (fi) 1978-10-26
FR2388564B1 (fr) 1980-07-25
IL54390A (en) 1980-11-30
NO153010B (no) 1985-09-23
ZA781832B (en) 1979-03-28
NL7804182A (nl) 1978-10-27
HU179290B (en) 1982-09-28
IL54390A0 (en) 1978-06-15
ATA292278A (de) 1980-01-15
LU79508A1 (fr) 1978-09-29
AR218304A1 (es) 1980-05-30
BE853923A (fr) 1977-10-25
SE430752B (sv) 1983-12-12
SE7804116L (sv) 1978-10-26
PT67868B (en) 1979-10-10
CH641047A5 (en) 1984-02-15
FI59535B (fi) 1981-05-29
GB1593567A (en) 1981-07-22
IT1113070B (it) 1986-01-20
FI59535C (fi) 1981-09-10
NO153010C (no) 1986-01-02
US4235876A (en) 1980-11-25
DE2817891A1 (de) 1978-11-09
IE780811L (en) 1978-10-25
AT358166B (de) 1980-08-25
PT67868A (en) 1978-05-01

Similar Documents

Publication Publication Date Title
FR2388564A1 (fr) Nouveau vaccin vivant ameliore contre la pseudopeste aviaire et son procede de preparation
EP0427246B1 (fr) Compositions pharmaceutiques contenant comme principe actif des acides carboxyliques soufrés ainsi que leur utilisation dans la lutte contre les rétrovirus
GR890100467A (el) Μεθοδος δια την παρασκευη ενδοφλεβιου φαρμακευτικης συνθεσεως.
FR2512670B1 (fr) Capsules contenant le principe actif d'un allergene et procede pour leur preparation
EP0003007A3 (en) Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
KR890009967A (ko) 아데노신 유도체
SE425253B (sv) Forfarande for framstellning av fysiologiskt aktiva foreningar betecknande ml-236 genom odling av stammar tillhorande den kenda arten penicillium citrinum samt utvinning
FR2408352A1 (fr) Vaccin contre le cholera de la volaille
FR2357256A1 (fr) Vaccins vivants ameliores contre la pseudopeste aviaire et leur procede de preparation
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
EP0315591A3 (en) Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them
LU80235A1 (fr) Analogues de la prostaglandine e1,compositions pharmaceutiques les contenant et procede de preparation
ES439804A1 (es) Un procedimiento para la preparacion de aminas.
FR2361877A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur preparation et medicament les contenant
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
FR2401132A1 (fr) Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant
BE750053A (fr) Derives de l'acide thiocarbamique, leur procede de preparation et leur emploi comme insecticides et acaricides
BE756980A (fr) Nouveaux dérivés d'acides 2-chloréthane-(thiono)-phosphoniques, leurs procédé de préparation et leur application à la régulation de croissande de
IT7829584A0 (it) Esteri 3-fenossi-alfa-vinil-benzilici di acidi vinil-ciclopropan-carbossilici, procedimento per la loro preparazione e loro impiego per combattere organismi nocivi.
GB1500300A (en) Pharmaceutical preparation for the treatment of circulatory disorders
BE773684A (fr) Nouveaux esters d'acides (thiono) phosphoriques (phosphoniques), leur procede de preparation et leur application comme insecticides et acaricides
FR2387974A1 (fr) Analogues de prostacycline et leur preparation

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse